📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
AUROBINDO PHARMA LTD.AUROPHARMAPharmaceuticals
Open
1145.3
High
1150.5
Low
1120.8
Close
1132.5
Volume
511867
Exchange
nse
Time
23-Jan-2026

Outlook

Score:

3.25

Rating:

FAIR

Candlestick Pattern

CandlepatternofAurobindoPharmais
None
EstimatedStoplossofAurobindoPharmais
1150.5
AurobindoPharmahasa
Bearishℹ
pattern.
Formationof
None
candlepatternindicatesthetrenddirectionofAurobindoPharmais
Unpredictableℹ
.

Trend

AurobindoPharmaisin
Sideways trendℹ
.
PriceofAurobindoPharmais
Downℹ
by

4.86

%.
Target
Buy@

1120.8

Sell@

1257.68

Current@

1132.5

Volume

ThetradevolumesofAurobindoPharmahavebecome
Deficientℹ
ThevolumetrendforAurobindoPharmais
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofAurobindoPharmais

Down

by

48.88

%

Valuation

ThecurrentmarketpriceofAurobindoPharmais
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth49784crandtotalassetsworth49784cr,thebalancesheetofAurobindoPharmais:
Balancedℹ
.
Cashflow
AurobindoPharmahas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 2178cr

.Itis
Upℹ
by

316.5

%.
66.21% i.e. ₹ 3924cr earned in operatingℹ
31.63% i.e. ₹ 1875cr spent in investingℹ
2.01% i.e. ₹ 119cr earned in financingℹ
0.15% i.e. ₹ 9cr earned in otherℹ
AurobindoPharmahas
Poorℹ
cashflowbecausethereis

Shortage

of

₹ 1006cr

.Itis
Downℹ
by

539.3

%.
32.44% i.e. ₹ 2434cr earned in operatingℹ
56.71% i.e. ₹ 4255cr spent in investingℹ
10.66% i.e. ₹ 800cr earned in financingℹ
0.19% i.e. ₹ 14cr earned in otherℹ
Income
TheincomeofAurobindoPharmais

₹ 8406cr

and

Profit

is:

₹ 846cr

AurobindoPharmaProfitisupby:

2.92

%andIncomeisUpby:

5.43

%
TheincomeofAurobindoPharmais

₹ 7973cr

and

Profit

is:

₹ 822cr

AurobindoPharmaProfitisdownby:

12.09

%andIncomeisDownby:

6.38

%
TheincomeofAurobindoPharmais

₹ 8516cr

and

Profit

is:

₹ 935cr

AurobindoPharmaProfitisupby:

10.91

%andIncomeisUpby:

4.68

%
By using this site you agree to the use of cookies to deliver a better site experience.